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Abstract 
Toluidine blue O (TBO) dye together with either silver (Ag) nanoparticles (NPs), gold (Au) NPs, or a 
mixture of Ag and Au NPs (Mix Ag-Au NPs) were incorporated into polyurethane to make 
antimicrobial surfaces using a swell-encapsulation-shrink process. Antimicrobial testing against 
Escherichia coli showed that inclusion of the NPs significantly enhanced the antimicrobial activities 
of the TBO polyurethane samples. In particular, samples containing Ag NPs exhibited potent 
antimicrobial activity under white light and surprisingly, also in the dark. The numbers of viable 
bacteria decreased below the detection limit on the TBO/Ag NPs incorporated samples within 3 h and 
24 h under white light and dark conditions. A mechanistic study using fufuryl alcohol indicated that 
the enhanced photobactericidal activity was most likely due to a type I photochemical reaction. To the 
best of our knowledge, this is the first report of an antimicrobial surface comprised of a combination 
of Ag NPs and a light activated agent to provide a dual kill mechanism. These surfaces are promising 
candidates for use in healthcare environments to reduce the incidence of hospital-acquired infections. 
 
Keywords: silver nanoparticles, gold nanoparticles, white light activated antimicrobial surface, 
toluidine blue O, E. coli bacteria  
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1. Introduction 
Healthcare-associated infections (HAIs) are infections acquired from the result of a person’s 
treatment by health care providers. HAIs in hospitals are caused by a variety of micro-organisms and 
cause a range of symptoms from minor discomfort for patients to prolonged and permanent disability 
and even death in some cases. [1, 2] HAIs include gastrointestinal infections (22%), urinary tract 
infections (20%), low respiratory tract infections (20%), surgical site infections (14%), skin and soft 
tissue infections (10%), bloodstream infections (7%) and others (7%). [3] Annually, there are at least 
300,000 incidents of HAIs in hospitalized patients in England, costing the UK’s National Health 
Service (NHS) >1 billion pounds a year. [3, 4] 
In recent years, the NHS has implemented a range of strategies, including mandatory surveillance, 
legislation, and inspection in order to decrease the number of HAIs. In particular, significant effort has 
been devoted to prevent HAIs attributed to meticillin resistant Staphylococcus aureus (MRSA), and 
Clostridium difficile because they have caused multiple fatalities. [5, 6] Although the actions have 
achieved a reduction in HAIs since 2007, fatality rate (~9000 deaths per year) is still tragically high 
and requires further control measures. [3] 
Contaminated surfaces in hospitals serve as a bacterial reservoir which is able to contribute to 
transmission of health care-associated pathogens via touch by patients and hospital workers. [7-10] 
Cleaning and/or disinfection of the surface have been used in hospitals to prevent surface 
contamination. [9-11] Although cleaning may decrease the levels of surface contamination, it is difficult 
to eradicate entirely because firstly, the bacteria may be strongly adherent to the surface [12] and even 
a small number of residual bacteria will quickly reproduce to significant numbers if environmental 
conditions are favourable. [13] Secondly, it is not easy to implement the cleaning and disinfection 
schemes thoroughly. Thus, it is necessary to develop effective and applicable alternatives to inhibit 
pathogen transmission in hospitals.  
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In order to prevent hospital surface contamination, a variety of techniques have been suggested 
including polyethylene glycol coatings, [14] easy-cleaning surfaces, [15, 16] silver or copper coated 
surfaces, [17-20] and photosensitization surfaces using light activated antimicrobial agents (LAAAs). [21-
23] Among them, surface treatment using LAAAs is considered promising because it can be easily 
applied to polymers which are widely used as hospital surfaces and in medical devices including 
tracheal or urinary catheters, and tubes for intravenous drips. [24] 
Crystal violet (CV), methylene blue (MB) and toluidine blue O (TBO) dyes are well known LAAAs. 
[25, 26] The agents produce reactive singlet oxygen (1O2) and reactive oxygen species (ROS) when 
exposed to a light source and these are toxic to bacteria. [25, 27] The free radicals and ROS cause adverse 
effects in bacteria such as loss of membrane integrity, inactivation of enzymes, and DNA damage. [28, 
29] The production of 1O2 and ROS is directly related to light intensity, and a ~ 600 nm laser was shown 
to be more efficient than white light from a hospital lamp due to higher flux. Additionally, [30, 31] the 
LAAAs have somewhat lower or no antimicrobial activity in the absence of light. [32] The antimicrobial 
activity of a LAAA is dependent on the concentration of the agent, the exposure time, and the intensity 
of light, and they are typically more effective against Gram-positive bacteria compared to Gram-
negative bacteria. [32, 33] 
With respect to surface application of LAAAs, previous studies showed MB, TBO, and CV dyes 
can be physically incorporated into polymers through a swell-encapsulation-shrink process and the 
dye impregnated polymer showed an inhibitory effect on bacteria with light exposure. [23, 30, 31, 34] 
Moreover, it was shown that in the TB or MB impregnated polymer, additional encapsulation of 2 nm 
gold (Au) nanoparticles (NPs) significantly enhanced the photobactericidal activities. [35] According 
to Noimark et al., (2012), the enhancement in the photosensitization of the dye impregnated polymer 
can be attributed to an increased dye triplet state production when 2 nm Au NPs are present. [34] 
Recently, studies of white light activated antimicrobial surfaces have been conducted because laser 
technology is not practical for use in the sterilization of touch surfaces commonly found in hospital 
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environments, whereas white light, from a common hospital light source, is easily applied. In previous 
studies, it was shown that TBO dye polymer with Au NPs had more potent photobactericidal effects 
than polymer containing MB dye polymer with the NPs under identical conditions [30] and that polymer 
containing CV dye with Au NPs resulted in a >4 log reduction in the numbers of both Gram-positive 
and Gram-negative bacteria within 6 h. [36, 37] Particularly, Noimark et al., (2014) showed that multi-
dye process and Au NPs incorporation showed a strong photobactericidal effect at relatively low light 
intensity and that they also showed significant antimicrobial activity in dark conditions. [38] 
In the present study, TBO dye polyurethanes with Ag NPs, Au NPs, and mixture of Ag and Au NPs 
(Mix Ag-Au NPs) were fabricated and tested for antimicrobial activity under white light and dark 
conditions. The Ag and Au NPs were synthesized in aqueous solution and they were mixed at a ratio 
of 1 to 1 in order to fabricate Mix Ag-Au NPs. In antimicrobial testing, the materials were potent 
against E. coli under white light and surprisingly, also in the dark. As far as we are aware, this is the 
first study to show that Ag NP enhances the effectiveness of a light activated dye. The modified 
polyurethane produced was one of the most potent antimicrobial surfaces ever reported, with 
extraordinary white light and dark kill of E. coli. 
2. Results and Discussion 
2.1. Synthesis of Nanoparticles 
Transmission electron microscopy (TEM) and energy-dispersive X-ray spectroscopy (EDS) were 
used in order to characterize the NPs. The NPs were made by citrate reduction of boiling aqueous 
solution of HAuCl3 and/or AgNO3. As shown in Figure 1 (a) and (b), both Ag and Au NPs had 
polydisperse sizes, respectively, and they are non-agglomerated. The mean size of Ag NPs was 22.4 ± 
16.7 nm with median of 22 nm, and interquartile range (IQR) of 24 nm and for Au NPs, it was 34.4 ± 
12.5 nm with median of 34 nm, and IQR of 12 nm (Figure S1 (a) and (b): Supporting information). 
They showed a variety of morphologies such as rod, sphere, ellipse, and triangle. EDS analysis 
confirmed that all of peaks were assigned to Ag and Au, respectively and impurities were not detected 
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(Figure 1 (d)). For Mix Ag-Au NPs, TEM and size analyses showed that most of the mixed NPs were 
agglomerated (Figure 1 (c)) and the mean size of the agglomerations was 252 ± 197.5 nm with median 
of 175 nm, and IQR of 200 nm (Figure S1 (c)). In EDS analysis (Figure 1 (d)), peaks, showed both Ag 
and Au, were confirmed in the particles.  
The UV-vis absorption spectra (Figure S2) of the Ag NPs suspension exhibited a peak at 409 nm, 
and the peak for Au NPs suspension was shown at 526 nm. In the mixture of Ag and Au NPs, a dual 
peak, which represent the individual Ag and Au NPs respectively, was shown.  
2.2. Characterization of White Light-Activated Antimicrobial Surfaces 
A simple swell-encapsulation-shrink process was employed to incorporate TBO dye, Au, and Ag 
NPs into polyurethane using acetone as a swelling solution. In the swell-encapsulation process, the 
TBO molecules and NPs in the acetone penetrate the polyurethane matrix as it swells, and the 
polyurethane then shrinks when it is removed from the solution. The TBO molecules and NPs remain 
inside of the polyurethane matrix.  
The polyurethane sample with various dying times were analyzed using fluorescence microscopy. 
The TBO fluorescence of thinly sliced sample side sections were imaged using CCD camera and the 
images were analyzed in order to confirm extension of the dye diffusion throughout the sample. Figure 
2 shows the diffusion of TBO dye inside polyurethane with increasing time. About two thirds of the 
sliced sample was shown on left side of each image and it provides the gradient of dye diffusion inside 
the polyurethane. Colour scale bar corresponds from low (black) to high fluorescence (white). As 
shown in the fluorescence images, at the beginning, absorption of the dye was predominantly near to 
the surface. With increasing immersion time, the dye diffused to throughout the sample and it was 
saturated after 1 h. This trend was shown in all of the treated samples, and there was no difference in 
fluorescence between 1 h and 24 h dyed samples. 
To determine NPs uptake from NPs suspension to polyurethane, The UV-vis spectra of NPs 
suspension were measured before and after swell-encapsulation-shrink process. The polymer sample 
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was immersed in a mixture of acetone (9 mL) and NPs (1mL) for 24 h. As shown Table 1, 8 % of Ag 
NPs in the suspension was absorbed to polyurethane sample and 32 and 25 % of Au NPs and Mix Ag-
Au NPs were permeated to the polymer, respectively (Figure S3).  
In order to produce antimicrobial polyurethane, samples were treated using TBO solutions 
containing Ag NPs, Au NPs, and Mix Ag-Au NPs for 24 h, and the UV-vis absorbance spectra of 
samples were measured over the wavelengths 350–950 nm. Figure 3 shows the absorbance spectra of 
control and treated samples. All of the treated samples gave a main absorption peak at 636 nm with 
the Ag NPs incorporated sample of highest intensity. However, the shoulder peaks of NPs embedded 
samples were different depending on the type of NPs (Ag: 595 nm, Au: 590 nm, Mix Ag-Au NPs: 592 
nm), and spectra of their absorbance were relatively broad, compared to that of TBO dyed sample. 
These indicated that the presence of Ag or Au NPs affected the position of the spectra feature. 
Additionally, the absorption of the Ag or Au NPs encapsulated samples was not confirmed. This is 
because of the low concentration of NPs in the sample or high absorbance of TBO.  
Water contact angle and elastic modulus of untreated, control, and TBO and NP treated polyurethane 
samples were measured. As shown in Table 2, untreated polyurethane gave water contact angles of 
99.9 o, indicating hydrophobicity. However, after 24 h swell-encapsulation, the contact angles of the 
samples decreased. In particular, the reduction on the control sample was the highest and it was 
approximately 29 o. After the treatment, all of the samples became hydrophilic except for the Ag NPs 
incorporated samples.  
Strain-stress tests were conducted in order to determine the physical change of polyurethane samples 
driven by swell-encapsulation. Elastic modulus is a number which represents the resistance of samples 
against elastic deformation. Swell-encapsulation caused a slight reduction of elastic modulus for all of 
the samples and the maximum reduction was approximately 9.1 MPa (Table 2). These results indicate 
that durability of the modified polyurethane against external force was lower compared to unmodified 
polyurethane, although still in a usable range. This trend is in agreement with previous research. [24] 
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The reduction of physical properties resulted from the swelling process because polyurethane is 
susceptible to acetone on long term and repeated exposures. [39] In addition, it was confirmed that NPs 
incorporation relieved the reduction of water contact angle and elastic modulus, and Ag NPs were 
more efficient than Au NPs in this respect.  
2.3. Antimicrobial Test  
The antimicrobial activity of the control, TBO dyed polyurethane samples, and TBO dyed 
polyurethane samples containing Ag or Au NPs alone, and Mix Ag-Au NPs under white light and dark 
conditions was tested against a representative strain of the Gram-negative bacterium, Escherichia coli, 
a key causative agent of HAI. [3] 25 µL of this bacterial suspension (containing 1.1×105 CFU) was 
inoculated onto the surface of each sample, and exposed to white light or incubated in the dark at room 
temperature for the same period of time. Figure 4 shows the distribution of white light intensity. Using 
a lux meter (LX-101, Lutron Inc., Coopersburg, PA, USA), it was measured at a distance of 30 cm 
from the light source. The intensity of the light ranged from 3900 to 5300 lx. In the dark, the light was 
completely blocked (0 lx). 
Figure 5 (a) and (b) show the antimicrobial activity of the samples after 3 h and 24 h incubation in 
the dark. After 3 h, no reduction in the numbers of viable bacteria was observed on the surfaces of the 
control material (polyurethane alone), polyurethane with TBO only, and polyurethane containing TBO 
and Au NPs. However, a statistically significant (P< 0.01) decrease in the number of viable bacteria 
was observed on the materials containing either TBO and Mix Ag-Au NPs (0. 34 log reduction in 
bacterial numbers) or TBO with Ag NPs alone (0.49 log reduction). After 24 h in the dark, the control 
material, polyurethane with TBO only, and polyurethane with TBO and Au NPs showed no significant 
reduction in bacterial viability whereas polyurethane containing TBO and Mix Ag-Au NPs or TBO 
with Ag NPs alone showed a significant reduction in the numbers of bacteria to below the limit of 
detection (P-value <0.01, detection limit: below 102 CFU/mL). 
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Additionally, in experiments of polyurethane containing NPs only, no reduction in the number of 
viable bacteria was confirmed after 3h incubation in dark (Figure 6 (a)). However, after 24 h in dark 
condition, a significant reduction was observed on polyurethane with Mix Ag-Au NPs only (P-value 
<0.01, 2.39 log reduction) or Ag NPs only (P-value <0.01, detection limit: below 102 CFU/mL) (Figure 
6 (b)).  
At 3 h incubation in dark, it was observed that polyurethanes containing the NPs and TBO have 
stronger dark kill than polyurethane with NPs only (P-value <0.01) although the difference between 
TBO/Ag NPs and Ag NPs only was not observed at 24 incubation in dark. These results indicate that 
although the NPs embedded in surface of polyurethane show an antimicrobial activity, a synergistic 
effect induced by incorporation of TBO and NPs produce stronger antimicrobial activity. 
Silver and gold NPs used in this study are widely known antimicrobial inorganic material and they 
boast a broad antimicrobial spectrum. [40, 41, 42, 45, 46, 47] However, the antimicrobial intensity of them is 
clearly different. According to a previous study, [48] Ag NPs have some intrinsic antimicrobial activity 
as Au NPs were required at 200 times higher concentration than that of Ag in order to get comparable 
the efficiency. This trend is in agreement with our experimental results. 
Figure 5 (c) shows the antimicrobial activities of control and modified samples under white light. 
In contrast to the samples incubated in the dark, all of the modified samples demonstrated strong 
photobactericidal activities after 3 h white light exposure (all modified samples: P <0.01). Compared 
to the control sample, 0.74 log and 1.9 log reductions in the numbers of viable bacteria were observed 
on polyurethane/TBO and polyurethane/TBO/Au NPs, respectively. The materials containing TBO 
and Mix Ag-Au NPs or TBO with Ag NPs alone showed a reduction in the numbers of viable bacteria 
to below the detection limit after 3 h exposure to white light. After 3 h white light exposure, no 
difference in photobactericidal activity between polyurethane containing Mix Ag-Au NPs and 
polyurethane containing Ag NPs alone was apparent as in both cases, the numbers of viable bacteria 
were below the detection limit. Therefore, 2 h white light exposure was tested. As shown in Figure 5 
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(d), the photobactericidal activity of Mix Ag-Au NPs incorporated sample at 2 h was much weaker 
than that of 3 h light exposure giving a reduction in bacterial numbers of only 1.48 log. However, the 
sample including Ag NPs still displayed potent photobactericidal activity after only 2 h of light 
exposure resulting in a 4.2 log reduction in the number of viable bacteria. The increased bactericidal 
activity displayed by the material containing Ag alone is presumably the result of a higher Ag content 
compared to the material containing the Mix Ag-Au NPs.  
In previous studies, it was reported that both free radical and ROS have a short diffusion distance of 
<220 nm. [38, 49, 50] Thus, it is speculated that TBO dye and NPs impregnated within the polyurethane 
are redundant in terms of their contribution to antimicrobial activity. Only the dye and NPs 
incorporated near to the polyurethane surface would be able to act as a photosensitiser able to kill 
surface-colonising bacteria. 
Incorporation of NPs into polyurethanes without TBO did not reinforce photobactericidal activity 
(Figure 6 (c)) while incorporation of NPs into the samples containing TBO successfully enhanced the 
photobactericidal activity. This indicates that there was an interaction between the dye molecules and 
NPs that induce an enhancement of the activity.  
The photobactericidal activity can explained as follows; under white light condition, TBO molecules 
in polyurethane are excited to a high energy triplet state from a low ground state. The triplet state dye 
reacts via type I (biomolecular reaction) or/and type II (reaction of molecular oxygen) photochemical 
pathways to produce ROS and 1O2 leading to bacterial death. It was speculated that NP incorporation 
enhances type I or type II photochemical reaction of the dye molecules. [36] To determine enhancement 
of 1O2 generation, measurement of singlet oxygen was conducted. Fufuryl alcohol, which has been 
widely used as a chemical trap of 1O2, was used. 
[61] 200 µL DI water containing 5.75 ×10-8 M of 
fufuryl alcohol used at each sample to measure the 1O2 concentration. At 222 nm wavelength, the 
consumption of fufuryl alcohol was monitored because the loss of fufuryl alcohol attributes to reaction 
with 1O2. Although after 3h of white light exposure, the generation of 
1O2 was observed on treated 
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samples, the concentrations of 1O2 produced from TBO only dyed polyurethane, TBO dyed 
polyurethane with Au NPs, TBO dyed polyurethane with Mix Ag-Au NPs, and TBO dyed 
polyurethane with Ag NPs were similar. This result indicates that the NPs incorporation did not 
enhance type II photochemical reaction to produce 1O2. Thus, it is speculated that the enhancement of 
photobactericidal activity resulted from increase of type I photochemical reaction caused by NPs. 
A similar effect in terms of light activated antimicrobial dye agent and Au NPs was shown by 
previous researches, [30, 35, 37] whereas in case of Ag NPs, it was not reported. Our experimental results 
showed that Ag NPs incorporated sample had >2.54 log higher photobactericidal activity than Au NPs 
under 3 h of white light exposure, and even showed a potent photobactericidal effect after 2 h resulting 
in a 4.2 log reduction in the number of viable bacteria. This indicates that Ag NPs are better at 
enhancing photobactericidal activity than Au NPs.  
Our study shows for the first time that encapsulation of Ag NP in TBO impregnated polymer 
significantly enhances photobactericidal activity. To validate the antimicrobial efficacy of Ag NPs 
incorporated white light-activated antimicrobial surface (WLAAS), photobactericidal activity was 
compared with the results of previous studies. The study of Ag NPs coated titania thin film showed 
that Ag NPs could enhance photobactericidal activity of the film. When tested against E. coli using a 
white light intensity of 5000 lx, the film showed a lethal photosensitization, producing 4.4 log 
reduction in bacterial viability within 6 h. [52] Our work shows that the combination of Ag NPs and 
TBO dye produces stronger photobactericidal activities against bacteria than that of Ag NPs and titania 
because with a white light intensity of average 4400 lx, our combination reduced the numbers of viable 
bacteria to below the detection limit within 3 h. Moreover, compared to multi-dyed WLAAS [37] and 
zinc oxide NPs incorporated polymer [53] which our group has previously shown to have excellent 
antimicrobial activity, Ag NPs with TBO incorporated surface was able to reduce the number of 
bacteria to below the detection limit in half the time in white light of comparable intensity. Similarly, 
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in the dark, TBO plus Ag NPs also showed unprecedented antimicrobial activity. To the best of our 
knowledge, this is the most potent WLAAS reported to date. 
It is expected that Ag incorporated polymer could be used to develop antimicrobial surfaces for 
clinical environments and also for various appliances such as keyboards, mobile phones, and tablet 
covers, and toilet and kitchen surfaces. For real world application of the polymer, adverse effects on 
human health should be considered. As Ag NPs used in this study have been widely used in food 
industry, medicine, and water quality control, [54-60] studies of their toxicity have been extensively 
conducted. The toxicity of Ag NPs is dependent on many factors, including size, dosage, and exposure 
time. [61] In vivo tests against mammals demonstrated that Ag NPs only had toxic effects at long term 
(28–90 days) and high concentration dosages (inhalation: >104 particles/cm3, ingestion: >30 mg/kg). 
[62-64] Although TBO is classified as non-hazardous material by the Occupational Safety and Health 
Administration (OSHA) in the USA, and the National Occupational Health and Safety Commission 
(NOHSC) in Austria, it showed some toxicity following inhalation, ingestion or eye contact with high 
concentrations. [65-67] Thus, further studies of Ag NPs and TBO incorporated WLAAS on health effect 
are required for real world applications. 
3. Conclusion  
Using a simple swell-encapsulation shrink process, TBO in combination with Ag NPs and Au NPs, 
were incorporated into a key polymer used in healthcare applications. Incorporation of Ag NPs and 
TBO dyed into polyurethane resulted in potent WLAASs that not only induced the lethal 
photosensitisation of E. coli within 3 h, but demonstrated strong bactericidal activity under dark 
conditions (24 h), reducing bacterial viability to below the detection limit. These WLAASs show 
unprecedented antimicrobial activity, achieving high bacterial kills under dark conditions, in addition 
to a light-activated kill mechanism for enhanced bactericidal activity. It is anticipated that these potent 
WLAASs will be used in healthcare applications to reduce surface bacterial contamination and thus 
reduce the risk of HAIs 
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4. Experimental Section 
4.1.Preparation of Chemical Stock Solutions 
Solution A: 49.2 mg (0.125 mM) of HAuCL4·3H2O (Gold (III) chloride trihydrate, Sigma-Aldrich, 
St. Louis, MO, USA) was dissolved in 25 mL of deionised (DI) water to get a 5 mM solution.  
Solution B: 45 mg (0.26 mM) of AgNO3 (Silver nitrate, Sigma-Aldrich, St. Louis, MO, USA) was 
dissolved in 50 mL of DI water to produce an approximately 5 mM solution.  
Solution C: 294.7 mg (1 mM) of Na3C6H5O7·2H2O (tri-sodium citrate dihydrate, Hopkin & 
Williams Ltd, London, UK) was dissolved in 50 mL of DI waster to form a 20 mM solution. 
4.2.Synthesis of Gold (Au) Nanoparticles (NPs) 
1 mL of solution A was mixed with 18 ml of DI water and heated with constant stirring. After the 
mixture was boiled for ~2 min, 1 mL of solution C was added. With constant stir, the mixture was 
boiled for a further 30 min and then allowed to cool. During the process, a scarlet color developed.  
4.3.Synthesis of Silver (Ag) Nanoparticles (NPs) 
1 mL of solution B was mixed with 18 mL of DI water and heated with constant stir. After the 
mixture was boiled for ~2 min, 1 mL of solution C was added. With constant stir, the mixture was 
boiled for a further 30 min and then allowed to cool. The development of a yellow colour was observed 
during the process. 
4.4.Mixture of Ag and Au NPs (Mix Ag-Au NPs) 
Mixture of Ag and Au NPs (Mix Ag-Au NPs) were prepared by mixing solutions of Ag and Au NPs. 
The combination was conducted at a ratio of 1 to 1 in volume. The color of the Mix Ag-Au NPs 
solution was purple.  
4.5.Preparation of White Light-Activated Antimicrobial Surface  
Toluidine blue O (TBO, Sigma-Aldrich, St. Louis, MO, USA) (Figure S4) solutions were prepared 
at concentration of 600 ppm in a mixture of acetone (9 mL), and DI water or NPs (1 mL). The solutions 
were sonicated in an ultrasound bath for 5 min in order to ensure complete dissolution of TBO powder. 
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Polyurethane (1.0×1.0 cm) were immersed in 10 mL of TBO solutions and left to swell in the dark for 
24 h. The polyurethane were recovered from the TBO and washed 2 times using DI water and then air-
dried for 24 h in the dark (Figure S5 (a)). The samples were prepared as follows: TBO only, TBO with 
Au NPs, TBO with Ag NPs and TBO with Au/Ag NPs.  
Additionally, NPs encapsulated polyurethane samples without TBO were prepared as follows: 
polyurethane with Au NPs, polyurethane with Ag NPs and polyurethane with Au/Ag NPs.  
4.6.Mechanical Properties 
Equilibrium water contact angle measurement on the polyurethane samples was conducted. A 
droplet (~5 µL) of deionised water was dropped onto the surface of the samples by gravity from a 
gauge 27 needle, the samples were photographed side on and the images was analyzed using Surftens 
4.5 software.  
Elastic stress of the samples was measured using material testing and inspection device (AGS-X, 
Kyoto, Japan) which is about 10 kN in capacity. The tensile grips action was used for samples with 
size of 0.8 mm (thickness) × 3 mm (width). From initial distance 30 mm between the grips the samples 
were stretched at a speed of 300 mm/min until final sample size equal to 5 times of initial one. The 
result was analyzed using Trapezium Lite X software. 
4.7.Antimicrobial Test  
The antimicrobial activities of the samples were tested against Escherichia coli (strain ATCC 25922) 
which was stored at –70oC in Brain-Heart-Infusion broth (Oxoid Ltd., Hampshire, England, UK) 
containing 20% (v/v) glycerol and propagated on MacConkey agar (Oxoid Ltd., Hampshire, England, 
UK). 10 mL of BHI broth was inoculated with one bacterial colony and cultured at 37 o C with shaking 
at 200 rpm. After incubation for 18 h, the bacteria were harvested by centrifugation, washed 2 times 
using phosphate buffered saline (PBS), and serially diluted in PBS for viable counts. The inoculum 
contained 4.6×106 colony forming units per mL (CFU/mL). 25 µL of this bacterial suspension 
(containing 1.1×105 CFU) was inoculated on to the surface of each sample and covered with a sterile 
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glass cover slip (2.2×2.2 cm) to ensure good contact between the bacteria and the sample surface. The 
samples were placed into plastic petri dishes containing moistened filter paper to maintain humidity 
and exposed to white light while an identical set of samples was maintained in the dark (Figure S5 (b)). 
After light exposure, the samples and cover slips were placed into 450 µL of PBS, and mixed using a 
vortex mixer for 1 min. The bacterial suspension was serially diluted, plated onto MacConkey agar, 
and incubated at 37 o C for 24 h. The colonies that grew on the plates were counted. 
4.8.Material Characterization  
 TEM (JEM-2100, JEOL Inc., Peabody, MA, USA) with EDS was used to confirm the size, 
morphology, and chemical composition of synthesized NPs.  
The UV-vis absorption spectra against NPs suspensions, control, and treated samples were measured 
using UV-Vis Spectrometer (PerkinElmer Inc., Winter St., CT, USA). Absorption was measured from 
350 to 900 nm (Figure S6).  
For investigating the diffusion of TBO inside polyurethane, flat samples were dyed for 5, 30, and 
60 min. Their side sections were sliced into 400 µm thickness using a scalpel and were mounted on 
glass slides for fluorescence imaging. The samples were imaged using an inverted fluorescence 
microscope (Model-IMT-2, Olympus Ltd., Tokyo, Japan) with cooled scientific-grade 16-bit digital 
CCD camera (Model- PIXIS 512, Roper industries Ltd., Sarasota, FL, USA) operated by Win-Spec 
software. The samples were detected using fluorescence excitation with a 633 nm laser. Fluorescence 
was detected using a bandpass filter centered at 660 nm (model-660DF30, Omega Optical Inc., 
Brattleboro, VT, USA). The images were subsequently analyzed using WinSpec/32 (Roper industries 
Ltd., Sarasota, FL, USA) and ImageJ software (\ \http://rsbweb.nih.gov/ij/). 
To determine the amount of NPs encapsulated into polyurethane sample, The UV-vis absorbance 
spectra of NP suspension were measured before and after swell-encapsulation-shrink process. The 
polyurethane sample was immersed in a mixture of acetone (9 mL), and NPs (1 mL) for 24 h. The 
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comparison of absorbance at 409 (Ag NPs) and 526 nm (Au NPs) or both at 409 and 526 nm (Mix Ag-
Au NPs) was enable determination of the amount of NP absorbed in the polymer.  
The uptake rate of NPs from NPs suspension to polyurethane sample was calculated as follow;  
Uptake rate (%) =  100 ×  (
AUbefore−AUafter
AUbefore
)   (1) 
Where AUbefore represents the absorbance of NP suspension before polyurethane immersion in the 
solution and AUafter shows the absorbance of NPs suspension after the polymer removal 
Singlet oxygen assay 
To measure the amount of singlet oxygen, 1.2 ×10-5 M of fufuryl alcohol (Sigma-Aldrich, St. Louis, 
MO, USA) was mixed with 40 mL of DI water, 200 µL of the solution was inoculated on control and 
treated samples, and then the samples were exposed to white light source for 3 h. 3 samples were used 
at each condition. After the light exposure, solution (600 µL) collected from three samples was loaded 
into quartz cuvette (volume: ~700 µL). At the wavelength of 222 nm, the consumption of fufuryl 
alcohol was monitored using UV-vis spectrometer. 
4.10. Statistical Analyses 
T-statistics of experimental data were calculated using the SPSS statistical software, version 12.0 
(SPSS, Inc., Chicago, IL, USA). 
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Table Legend  
Table.1. NPs uptake rate from the NPs suspension to polyurethane sample. 
Table.2. Water contact angle and elastic stress on untreated, control, and treated polyurethane samples. 
 
Figure Legends 
Figure 1. TEM images of (a) Ag NPs, (b) Au NPs, and (c) Mix Ag-Au NPs, and (d) EDS analysis for 
synthesized Ag NPs, Au NPs, and Mix Ag-Au NPs. 
Figure 2. Distribution of TBO dye after swell encapsulation for (a) 5 min, (b) 30 min, and (c) 60 min 
in polyurethane. Colour scale bar corresponds from low (black) to high fluorescence (white). 
Figure 3. UV-vis absorption spectra of control, TBO dyed sample, and TBO dyed polyurethane 
containing Ag NPs, Au NPs, and Mix Ag-Au NPs.  
Figure 4. Intensity distribution of white light used for irradiation of polyurethane. The intensity was 
measured at a distance of 30 cm from a 28 W hospital fluorescent lamp using a lux meter. Colour scale 
bar corresponds from low (blue) to high light intensity (red). 
Figure 5. Antimicrobial activities of control and treated polyurethane samples on E. coli: (a) 3 h and 
(b) 24 h incubation in the dark, and (c) 3 h and (d) 2 h incubation in white light. E. coli was placed in 
contact with the materials and exposed to light intensities ranging from 3900 to 5300 lx. In all tests, 
the temperature was maintained at a constant 20 o C in an incubator.  
Figure 6. Antimicrobial activities of control and treated polyurethane samples without TBO on E. coli: 
(a) 3 h and (b) 24 h incubation in the dark, and (c) 3 h incubation in white light. E. coli was placed in 
contact with the materials and exposed to light intensities ranging from 3900 to 5300 lx. In all tests, 
the temperature was maintained at a constant 20 o C in an incubator.  
Figure S1. Size distributions of Ag nanoparticles (NPs), Au NPs, and Mix Ag-Au NPs. In order to 
confirm the size of NPs, 20 TEM images of each NP sample were analyzed using imageJ software.  
Figure S2. UV-vis absorption spectra of Ag, Au, and Mix Ag-Au NPs suspension. 3 ml of NPs 
suspension at each condition was used to confirm UV-vis absorbance spectra, and it was measured 
within the wavelengths 350–950 nm. 
Figure S3. UV-vis absorption of Ag NPs, Au NPs, and Mix Ag-Au NPs suspension before and after 
swell-encapsulation-shrink process using UV-vis spectrometer. Polyurethane sample was immersed in 
a mixture of acetone (9 mL), and DI water or NPs (1 mL) for 24 h. Absorbance reductions of Ag and 
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Au NPs suspension were measured at 409 nm and 526 nm, respectively. The reduction of Mix Ag-Au 
NPs suspension was measured at both 409 nm and 526 nm.  
Figure S4. Chemical structure of toluidine blue O (TBO) 
Figure S5. (a) Preparation of light activated antimicrobial surfaces and (b) antimicrobial testing  
Figure S6. UV-vis absorption measurement using UV-vis spectrometer 
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Table.1. NPs uptake rate from the NPs suspension to polyurethane sample. 
Sample 
 NPs Uptake from NPs suspension  
to polyurethane sample (%) 
 
Ag NPs 
 
8 ± 0.5a 
 
Au NPs  32 ± 7 
 
Mix Ag-Au NPs  
 
25 ± 14 
 
aAverage water contact angle ± standard deviation 
 
Table.2. Water contact angle and elastic stress on untreated, control, and treated polyurethne samples. 
Sample 
 
Water contact angle  
( o ) 
 
Elastic modulus 
(MPa) 
 
Untreateda 
 
99.9 ± 0.7c 
 
15.1 ± 1.9 
 
Controlb  70.5 ± 0.9 
 
8.3 ± 0.4 
 
TBO only 
 
84.4 ± 0.9 
 
6.0 ± 0.6 
 
TBO with Ag NPs 
 
90.6 ± 0.8 
 
9.6 ± 0.8 
 
TBO with Au NPs 
 
88.9 ± 1.1 
 
7.6 ± 0.4 
 
TBO with Mix Ag-Au NPs   89.8 ± 2.1 
 
8.7 ± 0.1 
 
a Untreated polyurethane 
b Acetone treated polyurethane 
c Average water contact angle ± standard deviation 
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Figure 1. TEM images of (a) Ag NPs, (b) Au NPs, and (c) Mix Ag-Au NPs, and (d) EDS analysis for 
synthesized Ag NPs, Au NPs, and Mix Ag-Au NPs. 
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Figure 2. Distribution of TBO dye after swell encapsulation for (a) 5 min, (b) 30 min, and (c) 60 min 
in polyurethane. Colour scale bar corresponds from low (black) to high fluorescence (white). 
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Figure 3. UV-vis absorption spectra of control, TBO dyed sample, and TBO dyed polyurethane 
samples containing Ag NPs, Au NPs, and Mix Ag-Au NPs.  
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Figure 4. Intensity distribution of white light used for irradiation of polyurethane. The intensity was 
measured at a distance of 30 cm from a 28 W hospital fluorescent lamp using a lux meter. Colour scale 
bar corresponds from low (blue) to high light intensity (red). 
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Figure 5. Antimicrobial activities of control and treated polyurethane samples on E. coli: (a) 3 h and 
(b) 24 h incubation in the dark, and (c) 3 h and (d) 2 h incubation in white light. E. coli was placed in 
contact with the materials and exposed to light intensities ranging from 3900 to 5300 lx. In all tests, 
the temperature was maintained at a constant 20 o C in an incubator.  
a Colony forming unit/ mL :  Colony forming Unit (CFU) is a unit used to estimate the number of 
viable bacteria cells. 
*P-value < 0.01 
Below detection limit of 102 CFU 
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Figure 6. Antimicrobial activities of control and treated polyurethane (PU) samples without TBO on 
E. coli: (a) 3 h and (b) 24 h incubation in the dark, and (c) 3 h incubation in white light. E. coli was 
placed in contact with the materials and exposed to light intensities ranging from 3900 to 5300 lx. In 
all tests, the temperature was maintained at a constant 20 o C in an incubator.   
Below detection limit of 102 CFU   *P-value < 0.01 
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